Angela Betsaida B. Laguipo

Feature Writer

BSN Registered Nurse

Angela is a nurse by profession and a writer by heart. She graduated with honors (Cum Laude) for her Bachelor of Nursing degree at the University of Baguio, Philippines. She is currently completing her Master's Degree where she specialized in Maternal and Child Nursing and worked as a clinical instructor and educator in the School of Nursing at the University of Baguio.

Angela’s a passionate student who wants to excel in all types of writing, including handling posts in her college and university newspapers. She juggled writing and her studies way back in college.

Though she loved nursing as a profession, working as the school nurse in the same university she graduated from for six years, she decided to pursue her passion for writing. Since 2013, she wrote for various clients but focused more on health articles and medical health news, since it’s her forte and expertise.

For the past five years, she covered various topics ranging from medical, health, and science. She has written high-quality and well-researched content for a number of Science related media journals.

Her expertise in the medical and life sciences stems from her medical background as a nurse and her wide knowledge of health topics. Angela loves to research and come up with exciting yet informative articles that are easy to read and understand. She makes sure all her articles are simple but high-quality. Her focus is geared toward creating articles for all types of readers to understand.

She has been trained to write medical articles that can help not only healthcare professionals but other people who want to learn more about a disease or a health problem. She believes that everyone has the right to learn about health and its importance.

Since 2013, she has worked on many projects, from copywriting to medical writing, to creating blogs, e-books, and editorials. She is a full-time mother-of-three and a freelance health writer. Despite not practicing her profession in the healthcare setting, she is happy that she can somehow impart her knowledge and research skills to her readers, from all walks of life.

See less

Articles from Angela

Can fingerprick blood tests help evaluate antibody response and longevity against SARS-CoV-2 post-vaccination?

To monitor antibody level duration of vaccine-induced immune responses, a team of researchers in the U.S. – at Diacarta, University of California and VA Healthcare System, and the Franciscan University of Steubenville – evaluated the feasibility of using a single drop of fingerstick blood collected with flocked swabs for quantitative antibody response evaluation after COVID-19 vaccination.

20 Apr 2021

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

A recent study by researchers at the University of British Columbia (B.C.) shows that the benefits of continuing the COVID-19 vaccine of front-line workers with the AstraZeneca vaccine outweigh the increased risk of prothrombotic thrombocytopenia.

19 Apr 2021

U.S. vaccinates 131 million Americans against SARS-CoV-2

The country has jabbed over 131 million Americans (39.5% of the Total Population), including over 84 million who have been fully vaccinated (25.4%% of the Total Population).

19 Apr 2021

Numerous agents with anti-SARS-CoV-2 potential discovered with crystallographic screening

An international team of researchers focused on the macrodomain part of the non-structural protein 3 (Nsp3) gene product that SARS-CoV-2 uses to overturn the host cell’s natural antiviral response. The team provided a template that can help develop novel antivirals that are direct-acting and can combat the current pandemic.

16 Apr 2021

SARS-CoV-2 can alter bone marrow macrophage (BMM)-to-osteoclast differentiation, study finds

Now, a team of researchers in China and Australia has shown that SARS-CoV-2 infection can affect bone marrow macrophage (BMM)-to-osteoclast differentiation, which may impact the skeletal system.

16 Apr 2021

More than half of COVID-19 patients report persistent symptoms 12-months after infection

In a new study, appearing on the pre-print server medRxiv*, researchers at the University of Trieste and Istituto Auxologico Italiano IRCCS in Italy report that more than half of patients with previous mild-to-moderate symptomatic COVID-19 complained of the persistence of at least one symptom 12-months after the onset of the illness.

15 Apr 2021

COVID-19 deadlier than cars for over 40s, study finds

The study, which appeared on the pre-print server medRxiv, presented mortality rates and case-fatality rates for COVID-19 compared with other historic leading causes of death in the United States.

15 Apr 2021

Ponatinib identified as a potent inhibitor of SARS-CoV2-induced cytokine storm

Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor Ponatinib is a potent inhibitor of the N-terminal domain (NTD) -mediated cytokine storm. Ponatinib is an oral drug used for the treatment of chronic myeloid leukemia (CML).

14 Apr 2021

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

The study, published in The Lancet, demonstrates that there is no evidence of a link between severe illness and death and lineage when comparing the B.1.1.7 lineage and other variants.

14 Apr 2021

SARS-CoV-2 viable 21 days in blood, mucus, semen, urine, but just 24 hours in breast milk

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), spreads through respiratory droplets and aerosols expelled when infected individuals cough, sneeze, breathe or sing.

13 Apr 2021